Vertiflex Procedure
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
For more information on our portfolio of pain management product offerings, visit: https://www.linkedin.com/showcase/boston-scientific-pain-management
Recent Legal Challenges Boston Scientific is currently facing multiple class action lawsuits related to securities violations and investor rights, which may impact the company's reputation and market stability. This presents an opportunity to position alternative or complementary solutions that address transparency, compliance, or risk management for healthcare firms.
Focus on Pain Management With a dedicated portfolio of pain management products and a strong showcasing presence at major scientific conferences, there is potential to partner with Boston Scientific to expand product offerings or enhance technological integrations in pain therapy devices.
Technological Infrastructure Using advanced tech stacks including Google Cloud, Elastic Stack, and cybersecurity measures like the NIST framework suggests Boston Scientific invests significantly in digital transformation, creating opportunities to offer integrated software solutions, data analytics, or cybersecurity enhancements.
Financial and Market Position Despite legal challenges, Boston Scientific’s substantial funding of $4.3 billion and revenue scale of up to $10 billion indicate a capacity to invest in innovative medical device technology, allowing sales efforts to focus on high-impact solutions such as advanced procedural equipment or data management tools for large-scale deployment.
Strategic Growth Potential With ongoing industry competition and new product development, engaging Boston Scientific with cutting-edge medical manufacturing technology, process optimization services, or R&D collaborations could help accelerate their innovation pipeline and strengthen their competitive position.
Vertiflex Procedure uses 8 technology products and services including PTC Creo, Fastly, cdnjs, and more. Explore Vertiflex Procedure's tech stack below.
| Vertiflex Procedure Email Formats | Percentage |
| FLast@vertiflexspine.com | 76% |
| Last@vertiflexspine.com | 21% |
| First.Last@vertiflexspine.com | 3% |
| FLast@vertiflex.com | 100% |
| First.Last@bostonscientific.com | 76% |
| FLast@bostonscientific.com | 9% |
| First_Last@bostonscientific.com | 8% |
| First@bostonscientific.com | 7% |
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
For more information on our portfolio of pain management product offerings, visit: https://www.linkedin.com/showcase/boston-scientific-pain-management
Vertiflex Procedure has raised a total of $4.3B of funding over 1 rounds. Their latest funding round was raised on Feb 25, 2019 in the amount of $4.3Bas a debt offering.
Vertiflex Procedure's revenue is estimated to be in the range of $1M$10M
Vertiflex Procedure has raised a total of $4.3B of funding over 1 rounds. Their latest funding round was raised on Feb 25, 2019 in the amount of $4.3Bas a debt offering.
Vertiflex Procedure's revenue is estimated to be in the range of $1M$10M